| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Principal Accounting Officer | Principal Accounting Officer
1 company
James Kihara is Principal Accounting Officer at ACAD. From February 2022 to June 2026, the filings on record show 0 open-market purchases and 25 sales. James Kihara's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $269K at current prices.
Historically, James Kihara's trades have earned a middling insider score of 61/100 across 26 rated trades. Over a 12-month horizon, 64.7% of those trades were profitable, with an average 12-month return of +6.2%.
The ACAD filings lean toward selling, a net 57,688 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 10, 2023 | ACAD Acadia Pharmaceuticals Inc | Principal Accounting Officer | Sale+OE | 523 | $18.14 | $9,487.22 | -9.1% | +39.2% | +2.0% | |
| Apr 6, 2023 | ACAD Acadia Pharmaceuticals Inc | Principal Accounting Officer | Sale+OE | 701 | $18.16 | $12,730.16 | -14.2% | +31.7% | -1.9% | |
| Feb 24, 2023 | ACAD Acadia Pharmaceuticals Inc | Principal Accounting Officer | Sale+OE | 350 | $18.78 | $6,573.00 | -10.7% | +29.2% | +31.0% | |
| Apr 8, 2022 | ACAD Acadia Pharmaceuticals Inc | Principal Accounting Officer | Sale+OE | 1,025 | $27.05 | $27,726.25 | -29.6% | -39.6% | -31.5% | |
| Feb 23, 2022 | ACAD Acadia Pharmaceuticals Inc | Principal Accounting Officer | Sale+OE | 359 | $23.80 | $8,544.20 | -42.7% | -35.3% | -22.6% |